HEALTHSTORY 1065· JULY 4, 2026

Roche Drug Sets New Standard for KRAS-Driven Lung Cancer

A Roche drug has established a new treatment standard for KRAS-driven lung cancer, STAT+ reported, marking a significant moment in an oncology target that has long resisted effective therapy. The news lands as the broader biotech sector's…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 1064FBI Director Kash Patel Filed Late Disclosure on Strategy Stock, Reports Say NEXT STORY 1066 →North Island Credit Union Collects School Backpacks for San Diego Youth Through Boys & Girls Clubs Partnership

Keep reading

More from the desk.

01HEALTH

Novo Nordisk May Have Gained Extra Benefit From Trump Deal

The short version: Novo Nordisk may have secured an additional financial advantage from its agreement with the Trump administration to lower obesity drug costs for seniors. This potential benefit sits on top of the existing deal. An MFN…

health2 MIN

08HEALTH

Heidi Overton faces key moment at FDA confirmation hearing

Heidi Overton is nominated to lead the Food and Drug Administration, a regulatory body tasked with approving medicines and ensuring product safety. The short version is that she faces a critical test at her confirmation hearing, where she…

health2 MIN

11HEALTH

FDA replaces animal testing terms in new drug safety rule

The federal government has updated its drug approval rules to allow human-based research methods to replace animal testing in many cases. This is the second major push by the Department of Health and Human Services this year to shift…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk